[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake

NCT03872778 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: [177Lu]-NeoB
DRUG: [68Ga]-NeoB
DRUG: LCZ696

Sponsor

Advanced Accelerator Applications